EirGenix Inc. (TPE:6589)
53.00
-0.20 (-0.38%)
Nov 17, 2026, 1:30 PM CST
EirGenix Market Cap
EirGenix has a market cap or net worth of 15.83 billion as of November 17, 2026. It is the 14,408th most valuable company in the world and the 459th biggest in Taiwan. Its market cap has decreased by 36.05% in one year.
Market Cap
15.83B
Enterprise Value
14.83B
Revenue
1.48B
Global Rank
Country Rank
#459 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 15.83B, an increase of 247.30%. That is a compound annual growth rate of 13.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 15.83B | -15.22% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.18B |
| Steminent Biotherapeutics | 21.07B |
| Sunmax Biotechnology | 20.94B |
| CHO Pharma | 18.19B |
| TaiMed Biologics | 17.40B |
| Gongwin Biopharm Holdings | 15.14B |
| Medigen Vaccine Biologics | 14.79B |
| Lumosa Therapeutics | 14.64B |